Zurich Cantonal Bank’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,623
| Closed | -$110K | – | 2672 |
|
|
2019
Q3 | $110K | Sell |
1,623
-300
| -16% | -$20.6K | ﹤0.01% | 1570 |
|
|
2019
Q2 | $112K | Buy |
1,923
+441
| +30% | +$26.1K | ﹤0.01% | 1556 |
|
|
2019
Q1 | $104K | Sell |
1,482
-491
| -25% | -$36.4K | ﹤0.01% | 1563 |
|
|
2018
Q4 | $127K | Hold |
1,973
| – | – | ﹤0.01% | 1459 |
|
|
2018
Q3 | $139K | Hold |
1,973
| – | – | ﹤0.01% | 1518 |
|
|
2018
Q2 | $99K | Buy |
1,973
+710
| +56% | +$28.2K | ﹤0.01% | 1655 |
|
|
2018
Q1 | $40K | Hold |
1,263
| – | – | ﹤0.01% | 2197 |
|
|
2017
Q4 | $43K | Hold |
1,263
| – | – | ﹤0.01% | 2157 |
|
|
2017
Q3 | $41K | Hold |
1,263
| – | – | ﹤0.01% | 1935 |
|
|
2017
Q2 | $41K | Hold |
1,263
| – | – | ﹤0.01% | 1887 |
|
|
2017
Q1 | $40K | Hold |
1,263
| – | – | ﹤0.01% | 1912 |
|
|
2016
Q4 | $37K | Hold |
1,263
| – | – | ﹤0.01% | 1908 |
|
|
2016
Q3 | $37K | Buy |
1,263
+208
| +20% | +$5.79K | ﹤0.01% | 1847 |
|
|
2016
Q2 | $27K | Hold |
1,055
| – | – | ﹤0.01% | 1887 |
|
|
2016
Q1 | $26K | Hold |
1,055
| – | – | ﹤0.01% | 1853 |
|
|
2015
Q4 | $37K | Buy |
1,055
+750
| +246% | +$20.1K | ﹤0.01% | 1613 |
|
|
2015
Q3 | $6K | Buy |
305
+182
| +148% | +$4.69K | ﹤0.01% | 2378 |
|
|
2015
Q2 | $3K | Hold |
123
| – | – | ﹤0.01% | 2136 |
|
|
2015
Q1 | $4K | Buy |
+123
| New | +$3.91K | ﹤0.01% | 2072 |
|
Zurich Cantonal Bank's GHDX Position: Q4 2019 in Review
Zurich Cantonal Bank sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 1,623 shares — an estimated $110K sold.
Zurich Cantonal Bank first reported a position in GHDX in Q1 2015 and held it in 19 quarters. The position peaked at $139K in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Zurich Cantonal Bank reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Zurich Cantonal Bank sold 1,623 Genomic Health, Inc. shares in Q4 2019, an estimated $110K.
- Zurich Cantonal Bank first reported a position in Genomic Health, Inc. in Q1 2015 and held it in 19 quarters.
- Zurich Cantonal Bank's Genomic Health, Inc. position peaked at $139K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.